Hernexeos (Zongertinib) Approved as the First Oral Targeted Treatment for HER2-Mutant Advanced Lung Cancer

Hernexeos (zongertinib) is a new pill for adults with a type of advanced lung cancer called non-small-cell lung cancer (NSCLC) that has a HER2 gene mutation that causes the cancer to grow and spread faster,… Read more

Brinsupri: First Once-Daily Tablet for Non-Cystic Fibrosis Bronchiectasis

Brinsupri (brensocatib) is a new oral medicine approved to treat a long-term lung disease known as non-cystic fibrosis bronchiectasis (NCFB) in adults and children ages 12 or older.It works by blocking an enzyme called DPP1,… Read more

Alhemo: A New Daily Injection to Help Prevent Bleeding in Hemophilia A and B

Alhemo (concizumab-mtci) is a medicine approved to help prevent bleeding in people aged 12 or older with hemophilia A or B who don’t have inhibitors to certain blood clotting proteins.Hemophilia is a rare condition that… Read more

Modeyso (Dordaviprone) as First Treatment for Recurrent H3 K27M-Mutant Diffuse Midline Glioma

Modeyso (dordaviprone) is a new oral medicine that treats a rare and aggressive brain tumor, called diffuse midline glioma (DMG), that has a tumor mutation known to promote tumor growth, called an H3 K27M mutation.This… Read more

Vizz: New Daily Eye Drop to Improve Age-Related Blurry Near Vision

Vizz (aceclidine ophthalmic solution) is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as you get older.It’s the first and only eye… Read more

Skytrofa Approved as Once-Weekly Option for Adults With Growth Hormone Deficiency

Skytrofa (lonapegsomatropin-tcgd) is a long-acting version of human growth hormone (hGH).It is already approved for children with growth hormone deficiency (GHD) and is now approved for adults with GHD.It slowly releases somatropin, the active form… Read more

Leqvio: New Injectable Option for Lowering Bad Cholesterol Without Statins

Leqvio (inclisiran) is a prescription injection that helps lower levels of low-density lipoprotein cholesterol (LDL), often called “bad” cholesterol, which is a major risk factor for heart disease, heart attack, and stroke. It works by… Read more

Xocova: FDA Approves First Oral Post-Exposure Prophylaxis to Help Prevent COVID-19 in Adults and Adolescents 12 and Older

Xocova (ensitrelvir) is a prescription antiviral medicine you take by mouth to lower your chance of getting COVID-19 after you have been in close contact with someone who has the virus.It is approved for adults… Read more

Zaynich: FDA Approves New IV Antibiotic for Complicated Urinary Tract Infections in Adults

Zaynich (cefepime and zidebactam) is an intravenous (IV) antibiotic that is FDA-approved for adults with complicated urinary tract infections (cUTIs) that are caused by certain Gram-negative bacteria. Unlike a typical UTI, a cUTI usually affects… Read more

Trutakna: A New Weekly Shot to Help Adults With IgA Nephropathy

Trutakna (atacicept) is an injection that is approved for adults with a kidney disease called primary immunoglobulin A nephropathy, or IgAN. It is a type of medicine known as an immunomodulator. People with IgAN make… Read more